HCVcc-IN-2
HCVcc-IN-2 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. HCVcc-IN-2 has high inhibition against the three cell line from CNS cancer (SF-539 and SNB-75), colon cancer (HCT-116), and renal cancer (A498) [1].
Product Specifications
CAS Number
2977251-02-6
UNSPSC
12352005
Target
Virus Protease
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/hcvcc-in-2.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(N)C(C2=NC3=CC=CC=C3S2)=C(S[C@H]4[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@](OC(C)=O)([H])[C@@H](COC(C)=O)O4)S1)C5=CC=C(Br)C=C5
Molecular Formula
C32H29BrN2O10S3
Molecular Weight
777.68
References & Citations
[1]Azzam et al. Novel Thiophene Thioglycosides Substituted with the Benzothiazole Moiety: Synthesis, Characterization, Antiviral and Anticancer Evaluations, and NS3/4A and USP7 Enzyme Inhibitions. ACS Omega. 2022 Sep 29;7 (40) :35656-35667.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6283597-01 0.1 mL
CD9, NT (CD9, MIC3, TSPAN29, CD9 antigen, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein, Tetraspanin-29, p24, CD9) (MaxLight 750)
Sign In for Pricing
View Details MBS6283597-02 5x 0.1 mL
CD9, NT (CD9, MIC3, TSPAN29, CD9 antigen, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein, Tetraspanin-29, p24, CD9) (MaxLight 750)
Sign In for Pricing
View Details 
orb1652199-01 20 µg
Recombinant Human mRNA-decapping enzyme 2 (DCP2)
Sign In for Pricing
View Details